José María La Fuente

José María La Fuente

Auto-generated profile, based on publicly available information

José María La Fuente

Serviço de Urologia, Hospital Santo Antonio, Porto, Portugal

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
JAJavier Angulo
Javier Angulo
RGRocío González-Corrochano
Rocío González-Corrochano
PCPedro Cuevas
Pedro Cuevas
AFArgentina Fernández
Argentina Fernández
JFJosé M. La Fuente
José M. La Fuente
ITIñigo Sáenz de Tejada
Iñigo Sáenz de Tejada

1 May 2002 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JAJavier Angulo
Javier Angulo
PCPedro Cuevas
Pedro Cuevas
JFJose M. La Fuente
Jose M. La Fuente
JPJose M. Pomerol
Jose M. Pomerol
EREduardo Ruiz‐Castañé
Eduardo Ruiz‐Castañé
ITIñigo Sáenz de Tejada
Iñigo Sáenz de Tejada

1 September 2019 in Redox Biology
Verified
Journal Article
Open access
JAJavier Angulo
Javier Angulo
MAMariam El Assar
Mariam El Assar
ASAlejandro Sevilleja-Ortiz
Alejandro Sevilleja-Ortiz
AFArgentina Fernández
Argentina Fernández
ASAlberto Sánchez-Ferrer
Alberto Sánchez-Ferrer
LMLeocadio Rodríguez Mañas
Leocadio Rodríguez Mañas
Oxidative stress contributes to endothelial dysfunction, a key step in cardiovascular disease development. Ageing-related vascular dysfunction involves defective antioxidant response. Nuclear factor erythroid 2-like-2 (Nrf2), orchestrates cellular response to oxidative stress. We evaluated the impact of Nrf2-activation on endothelium-dependent and H2O2-mediated vasodilations in: aorta (RA), mesenteric artery (RMA), coronary artery (RCA) and corpus cavernosum (RCC) from ageing rats and in human penile arteries (HPRA) and corpus cavernosum (HCC) from erectile dysfunction (ED) patients. Relaxant responses were evaluated in organ chambers and wire myographs. Nrf2 content and heme oxygenase-1 (HO-1) were determined by ELISA. Superoxide and Nrf2 were detected by immunofluorescence. Pharmacological activation of Nrf2 with sulforaphane (SFN) improved NO- and endothelium-derived hyperpolarizing factor-mediated endothelium-dependent vasodilation and H2O2-induced relaxation in vascular beds from aging rats. SFN-induced effects were associated with increased Nrf2 (RMA, RCA) and reduced superoxide detection in RCA. Improvement of vascular function was confirmed in HPRA and HCC from ED patients and mimicked by another Nrf2 activator, oltipraz. Nrf2 increase and superoxide reduction together with HO-1 increase by Nrf2 activation was evidenced in HCC from ED patients. PDE5 inhibitor-induced relaxations of HPRA and HCC from ED patients were enhanced by SFN. Nrf2 short-term pharmacological activation attenuates age-related impairment of endothelium-dependent and reactive oxygen species (ROS)-induced vasodilation in different rat and human vascular territories by upregulation of Nrf2-related signaling and decreased oxidative stress. In ED patients target tissues, Nrf2 potentiates the functional effect of ED conventional pharmacological therapy suggesting potential therapeutic implication.

1 September 2012 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
JAJavier Angulo
Javier Angulo
PCPedro Cuevas
Pedro Cuevas
AFArgentina Fernández
Argentina Fernández
JFJosé M. La Fuente
José M. La Fuente
AAAntonio Allona
Antonio Allona
ITIñigo Sáenz de Tejada
Iñigo Sáenz de Tejada

27 February 2013 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
RGR González‐Corrochano
R González‐Corrochano
JFJm La Fuente
Jm La Fuente
PCP Cuevas
P Cuevas
AFA Fernández
A Fernández
MCMx Chen
Mx Chen
JAJ Angulo
J Angulo
Background and Purpose: We have evaluated the influence of calcium‐activated potassium channels (KCa) activation on cGMP‐mediated relaxation in human penile tissues from non‐diabetic and diabetic patients, and on the effects of PDE5 inhibitors on erectile responses in control and diabetic rats.Experimental Approach: Cavernosal tissues were collected from organ donors and from patients with erectile dysfunction (ED). Relaxations of corpus cavernosum strips (HCC) and penile resistance arteries (HPRA) obtained from these specimens were evaluated. Intracavernosal pressure (ICP) increases to cavernosal nerve electrical stimulation were determined in anaesthetized diabetic and non‐diabetic rats.Key Results: Concentration‐dependent vasodilation to the PDE5 inhibitor, sildenafil, in HPRA was sensitive to endothelium removal, NO/cGMP pathway inhibition and KCa blockade. Accordingly, activation of KCa with NS‐8 (10 μM) significantly potentiated sildenafil‐induced relaxations in HPRA (EC50 0.49 ± 0.22 vs. 5.21 ± 0.63 μM). In HCC, sildenafil‐induced relaxation was unaffected by KCa blockade or activation. Potentiating effects in HPRA were reproduced with an alternative PDE5 inhibitor (tadalafil) and KCa activator (NS1619) and prevented by removing the endothelium. Large‐conductance KCa (BK) and intermediate‐conductance KCa (IK) contribute to NS‐8‐induced effects and were immunodetected in human and rat penile arteries. NS‐8 potentiated sildenafil‐induced enhancement of erectile responses in rats. Activation of KCa recovered the impaired relaxation to sildenafil in diabetic HPRA while sildenafil completely reversed diabetes‐induced ED in rats only when combined with KCa activation.Conclusions and Implications: Activation of KCa improves vasodilatory capacity of PDE5 inhibitors in diabetic and non‐diabetic HPRA, resulting in the recovery of erectile function in diabetic rats. These results suggest a therapeutic potential for KCa activation in diabetic ED.

1 February 2009 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
JAJavier Angulo
Javier Angulo
CPConcepcion Peiro
Concepcion Peiro
PCPedro Cuevas
Pedro Cuevas
SGSonia Gabancho
Sonia Gabancho
AFArgentina Fernández
Argentina Fernández
ITIñigo Sáenz De Tejada
Iñigo Sáenz De Tejada